Literature DB >> 3681263

Strain variation of respiratory syncytial virus.

L A Morgan1, E G Routledge, M M Willcocks, A C Samson, R Scott, G L Toms.   

Abstract

Western blotting and immunoperoxidase staining with monoclonal antibodies were employed to analyse epitopic and polypeptide molecular weight variation among isolates of respiratory syncytial (RS) virus collected in Newcastle between 1965 and 1986. One group of isolates resembled the A2 and Long prototype subgroup A strains of RS virus in possessing a P protein of Mr 34,000. Isolates in this subgroup showed two patterns of reactivity with subgroup A-specific monoclonal antibodies to the G glycoprotein and 22K protein. Isolates with both reactivity patterns were isolated throughout the period studied. Isolates in the second group resembled the 8/60 subgroup B prototype strain in their lack of reactivity to subgroup A-specific monoclonal antibodies but were heterogeneous in P protein molecular weight. The earliest isolate only, made in 1965, possessed a P protein of Mr 31,000 resembling the prototype strain. All subsequent subgroup B isolates possessed a higher Mr, 33,000, P protein. Overall, subgroup A viruses were isolated most frequently although subgroup B strains may have predominated in some epidemics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681263     DOI: 10.1099/0022-1317-68-11-2781

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Antigenic characterization of respiratory syncytial virus group A and B isolates in Rio de Janeiro, Brazil.

Authors:  M M Siqueira; J P Nascimento; L J Anderson
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Distinguishing between respiratory syncytial virus subgroups by protein profile analysis.

Authors:  P Walpita; M A Mufson; R J Stanek; D Pfeifer; J D Connor
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan.

Authors:  K Nagai; H Tsutsumi; H Yamazaki; S Pattamadilok; S Chiba
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 4.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors:  J A Beeler; K van Wyke Coelingh
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

6.  Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.

Authors:  B García-Barreno; C Palomo; C Peñas; T Delgado; P Perez-Breña; J A Melero
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions.

Authors:  B García-Barreno; T Delgado; J A Melero
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology.

Authors:  G A Storch; C S Park; D E Dohner
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.

Authors:  W M Sullender; L Sun; L J Anderson
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

10.  Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

Authors:  Teresa R Johnson; Michael N Teng; Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.